These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4093988)

  • 1. Quinones as mutagens, carcinogens, and anticancer agents: introduction and overview.
    Smith MT
    J Toxicol Environ Health; 1985; 16(5):665-72. PubMed ID: 4093988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of metabolism and oxidation-reduction cycling in the cytotoxicity of antitumor quinoneimines and quinonediimines.
    Powis G; Hodnett EM; Santone KS; See KL; Melder DC
    Cancer Res; 1987 May; 47(9):2363-70. PubMed ID: 3032421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in metal-induced oxidative stress and human disease.
    Jomova K; Valko M
    Toxicology; 2011 May; 283(2-3):65-87. PubMed ID: 21414382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzo[a]pyrene dione-benzo[a]pyrene diol oxidation-reduction couples; involvement in DNA damage, cellular toxicity, and carcinogenesis.
    Lesko SA; Lorentzen RJ
    J Toxicol Environ Health; 1985; 16(5):679-91. PubMed ID: 3005601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells.
    Wislocki PG; Wood AW; Chang RL; Levin W; Yagi H; Hernandez O; Dansette PM; Herina DM; Conney AH
    Cancer Res; 1976 Sep; 36(9 pt.1):3350-7. PubMed ID: 788898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
    Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
    Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic mechanisms of anti-tumour quinones in parental and resistant lymphoblasts.
    Halinska A; Belej T; O'Brien PJ
    Br J Cancer Suppl; 1996 Jul; 27():S23-7. PubMed ID: 8763840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are reduced quinones necessarily involved in the antitumour activity of quinone drugs?
    Butler J; Hoey BM
    Br J Cancer Suppl; 1987 Jun; 8():53-9. PubMed ID: 3307874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of DT-diaphorase in cancer chemoprevention and chemotherapy.
    Begleiter A; Leith MK; Curphey TJ; Doherty GP
    Oncol Res; 1997; 9(6-7):371-82. PubMed ID: 9406243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimutagens, anticarcinogens, and effective worldwide cancer prevention.
    Weisburger JH
    J Environ Pathol Toxicol Oncol; 1999; 18(2):85-93. PubMed ID: 15281219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free radical formation by antitumor quinones.
    Powis G
    Free Radic Biol Med; 1989; 6(1):63-101. PubMed ID: 2492250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data mining the NCI cancer cell line compound GI(50) values: identifying quinone subtypes effective against melanoma and leukemia cell classes.
    Marx KA; O'Neil P; Hoffman P; Ujwal ML
    J Chem Inf Comput Sci; 2003; 43(5):1652-67. PubMed ID: 14502500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity of several classes of antitumor agents to Salmonella typhimurium TA98, TA100, and TA92.
    Seino Y; Nagao M; Yahagi T; Hoshi A; Kawachi T; Sugimura T
    Cancer Res; 1978 Jul; 38(7):2148-56. PubMed ID: 350383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics.
    Pritsos CA; Sartorelli AC
    Cancer Res; 1986 Jul; 46(7):3528-32. PubMed ID: 3011250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of phenotypes resembling CuZn-superoxide dismutase deletion in wild-type yeast cells: an in vivo assay for the role of superoxide in the toxicity of redox-cycling compounds.
    Wallace MA; Bailey S; Fukuto JM; Valentine JS; Gralla EB
    Chem Res Toxicol; 2005 Aug; 18(8):1279-86. PubMed ID: 16097801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unifying mechanism in the initiation of cancer and other diseases by catechol quinones.
    Cavalieri EL; Rogan EG
    Ann N Y Acad Sci; 2004 Dec; 1028():247-57. PubMed ID: 15650250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.